- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/18 - DibenzazepinesHydrogenated dibenzazepines
Patent holdings for IPC class C07D 223/18
Total number of patents in this class: 50
10-year publication summary
|
1
|
3
|
4
|
1
|
1
|
0
|
3
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7942 |
4 |
| Bristol-myers Squibb Company | 4863 |
3 |
| Samsung Display Co., Ltd. | 32798 |
2 |
| Sumitomo Chemical Company, Limited | 8988 |
2 |
| Kyoto University | 2778 |
2 |
| Nagase & Co., Ltd. | 225 |
2 |
| Rohm and Haas Electronic Materials Korea Ltd. | 330 |
2 |
| Vandria SA | 14 |
2 |
| Contineum Therapeutics, Inc. | 13 |
2 |
| Hoffmann-La Roche Inc. | 3267 |
1 |
| University of Southern California | 2077 |
1 |
| University of South Florida | 1827 |
1 |
| Aarhus Universitet | 405 |
1 |
| API Corporation | 228 |
1 |
| Cnrs | 103 |
1 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
1 |
| Domain Therapeutics | 45 |
1 |
| Guangzhou Kingmed Center for Clinical Laboratory | 15 |
1 |
| Hamari Chemicals, Ltd. | 32 |
1 |
| Hetero Research Foundation | 174 |
1 |
| Other owners | 18 |